Viatris Inc. (ETR:VIA)
7.64
-0.13 (-1.62%)
At close: Jun 3, 2025, 5:30 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2018 - 2020 |
Brands | 9.01B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Brands Growth | -7.03% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Complex Gx and Biosimilars | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Complex Gx and Biosimilars Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Generics | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Generics Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Generics | 5.27B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Generics Growth | -6.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2018 - 2020 |
Developed Markets | 8.66B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Developed Markets Growth | -6.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Greater China | 2.18B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Greater China Growth | 1.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
JANZ | 1.30B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
JANZ Growth | -6.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Emerging Markets | 2.14B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Emerging Markets Growth | -15.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|